ACCA · Question 03 · Cross-Border Corporate and Personal Taxation
SECTION B - ADVISORY REPORT
You are a tax consultant advising Med-Tech Solutions Ltd, a UK-resident company that manufactures specialized surgical equipment.
On 1 May 2024, Med-Tech Solutions Ltd acquired 100% of the ordinary share capital of Bio-Scan GmbH, a company resident in Germany. Bio-Scan GmbH manufactures complementary diagnostic devices. The German corporate tax rate is 15%. Bio-Scan GmbH is expected to generate profits of £1.2 million in the year ending 30 April 2025 and plans to pay a dividend of £500,000 to Med-Tech Solutions Ltd on that date.
To oversee the integration, Med-Tech Solutions Ltd has seconded one of its senior executives, Sarah, to Bio-Scan GmbH. Sarah moved to Germany on 1 July 2024. She signed a 3-year full-time employment contract to work exclusively in Germany. Prior to this, Sarah had lived in the UK her entire life. She retained her UK home, which is currently empty, but she has leased an apartment in Munich. She expects to return to the UK for 20 days during the 2024/25 tax year to visit family, taking no work days during these visits.
REQUIREMENT:
Prepare a report for the directors of Med-Tech Solutions Ltd and Sarah that:
(a) Advises Med-Tech Solutions Ltd on the UK corporation tax implications of receiving the dividend from Bio-Scan GmbH, and evaluates whether the Controlled Foreign Company (CFC) rules will apply to Bio-Scan GmbH's profits. (15 marks)
(b) Advises Sarah on her UK Statutory Residence status for the 2024/25 tax year, including the availability of split-year treatment, and explains how her employment income earned in Germany will be treated for UK income tax purposes. (10 marks)
SECTION B - ADVISORY REPORT
You are a tax consultant advising Med-Tech Solutions Ltd, a UK-resident company that manufactures specialized surgical equipment.
On 1 May 2024, Med-Tech Solutions Ltd acquired 100% of the ordinary share capital of Bio-Scan GmbH, a company resident in Germany. Bio-Scan GmbH manufactures complementary diagnostic devices. The German corporate tax rate is 15%. Bio-Scan GmbH is expected to generate profits of £1.2 million in the year ending 30 April 2025 and plans to pay a dividend of £500,000 to Med-Tech Solutions Ltd on that date.
To oversee the integration, Med-Tech Solutions Ltd has seconded one of its senior executives, Sarah, to Bio-Scan GmbH. Sarah moved to Germany on 1 July 2024. She signed a 3-year full-time employment contract to work exclusively in Germany. Prior to this, Sarah had lived in the UK her entire life. She retained her UK home, which is currently empty, but she has leased an apartment in Munich. She expects to return to the UK for 20 days during the 2024/25 tax year to visit family, taking no work days during these visits.
REQUIREMENT:
Prepare a report for the directors of Med-Tech Solutions Ltd and Sarah that:
(a) Advises Med-Tech Solutions Ltd on the UK corporation tax implications of receiving the dividend from Bio-Scan GmbH, and evaluates whether the Controlled Foreign Company (CFC) rules will apply to Bio-Scan GmbH's profits. (15 marks)
(b) Advises Sarah on her UK Statutory Residence status for the 2024/25 tax year, including the availability of split-year treatment, and explains how her employment income earned in Germany will be treated for UK income tax purposes. (10 marks)
How to approach this question
Full Answer
Common mistakes
Practice the full ACCA ATX — Advanced Taxation Practice Exam 2
3 questions · hints · full answers · grading
Expert